FUT8 alpha-(1, 6)-fucosyltransferase in cancer

K Bastian, E Scott, DJ Elliott, J Munkley - International Journal of …, 2021 - mdpi.com
Aberrant glycosylation is a universal feature of cancer cells that can impact all steps in
tumour progression from malignant transformation to metastasis and immune evasion. One …

Sialylation as an important regulator of antibody function

R Vattepu, SL Sneed, RM Anthony - Frontiers in Immunology, 2022 - frontiersin.org
Antibodies play a critical role in linking the adaptive immune response to the innate immune
system. In humans, antibodies are categorized into five classes, IgG, IgM, IgA, IgE, and IgD …

Afucosylated IgG responses in humans–structural clues to the regulation of humoral immunity

JJ Oosterhoff, MD Larsen, CE van der Schoot… - Trends in …, 2022 - cell.com
Healthy immune responses require efficient protection without excessive inflammation.
Recent discoveries on the degree of fucosylation of a human N-linked glycan at a conserved …

The ligands for human IgG and their effector functions

SW de Taeye, T Rispens, G Vidarsson - Antibodies, 2019 - mdpi.com
Activation of the humoral immune system is initiated when antibodies recognize an antigen
and trigger effector functions through the interaction with Fc engaging molecules. The most …

Role of Fc core fucosylation in the effector function of IgG1 antibodies

J Golay, AE Andrea, I Cattaneo - Frontiers in Immunology, 2022 - frontiersin.org
The presence of fucose on IgG1 Asn-297 N-linked glycan is the modification of the human
IgG1 Fc structure with the most significant impact on FcɣRIII affinity. It also significantly …

[HTML][HTML] Plasticity in pro-and anti-tumor activity of neutrophils: shifting the balance

C Furumaya, P Martinez-Sanz, P Bouti… - Frontiers in …, 2020 - frontiersin.org
Over the last decades, cancer immunotherapies such as checkpoint blockade and adoptive
T cell transfer have been a game changer in many aspects and have improved the treatment …

Antibody conjugates-recent advances and future innovations

D Leung, JM Wurst, T Liu, RM Martinez… - Antibodies, 2020 - mdpi.com
Monoclonal antibodies have evolved from research tools to powerful therapeutics in the past
30 years. Clinical success rates of antibodies have exceeded expectations, resulting in …

Genetic glycoengineering in mammalian cells

Y Narimatsu, C Büll, YH Chen, HH Wandall… - Journal of Biological …, 2021 - ASBMB
Advances in nuclease-based gene-editing technologies have enabled precise, stable, and
systematic genetic engineering of glycosylation capacities in mammalian cells, opening up a …

Strategies for glycoengineering therapeutic proteins

K Dammen-Brower, P Epler, S Zhu, ZJ Bernstein… - Frontiers in …, 2022 - frontiersin.org
Almost all therapeutic proteins are glycosylated, with the carbohydrate component playing a
long-established, substantial role in the safety and pharmacokinetic properties of this …

Harnessing the potential of machine learning for advancing “quality by design” in biomanufacturing

I Walsh, M Myint, T Nguyen-Khuong, YS Ho, SK Ng… - MAbs, 2022 - Taylor & Francis
Ensuring consistent high yields and product quality are key challenges in biomanufacturing.
Even minor deviations in critical process parameters (CPPs) such as media and feed …